Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong

Journal of Neurology, Neurosurgery & Psychiatry

Fecha de publicación: 27 de abril de 2021

Autores: Florence Sin Ying Fan, Terry C F Yip,  Brian Yiu, Bonnie Lam, Lisa Au, Alexander Yuk-lun Lau, Bonaventure Ip, Yannie Soo, Thomas W Leung, Timothy Li, Grace Lui, Grace L H Wong, Vincent Mok

DOI: http://dx.doi.org/10.1136/jnnp-2021-326286

Background: COVID-19 is caused by ß-coronavirus SARS-CoV-2. Recent reports suggested that neurological diseases, in particular stroke, dementia and advanced Parkinson’s disease (PD), were important predictors of COVID-19-related mortality. SARS-CoV was another ß-coronavirus which resulted in the epidemic of SARS in late 2002 to early 2003. Apparently, it remained quiescent since 2004 but its re-emergence is possible. Patients with SARS at advanced age and with multiple comorbidities were at higher risk of mortality.